Checkpoint Trends Ltd
₹ 93.6
2.00%
25 Nov
2:36 p.m.
About
Incorporated in 1991, Checkpoint Trends Ltd is in the business of trading and consultancy[1]
Key Points
- Market Cap ₹ 51.2 Cr.
- Current Price ₹ 93.6
- High / Low ₹ 93.6 / 9.41
- Stock P/E 35.3
- Book Value ₹ 3.60
- Dividend Yield 0.00 %
- ROCE 16.5 %
- ROE 9.17 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 26.0 times its book value
- The company has delivered a poor sales growth of -12.8% over past five years.
- Company has a low return on equity of 0.00% over last 3 years.
- Company has high debtors of 212 days.
- Working capital days have increased from 220 days to 387 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 121 | |
| 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 119 | |
| Operating Profit | -0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 |
| OPM % | -5% | 10% | -1% | -31% | 2% | 2% | -1% | -7% | 3% | 20% | 2% | ||
| 0 | -3 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0 | -3 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 2 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 20% | 0% | 50% | 0% | -50% | 40% | |
| -0 | -3 | -0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 1 | |
| EPS in Rs | -0.11 | -5.61 | -0.02 | 0.05 | -0.29 | -0.02 | 0.05 | 0.02 | -0.07 | -0.15 | 0.05 | 0.05 | 2.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -13% |
| 3 Years: | -37% |
| TTM: | 15172% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 38% |
| 3 Years: | 48% |
| TTM: | 863% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 115% |
| 3 Years: | 181% |
| 1 Year: | 572% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | 0% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -2 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 139 | |
| Total Liabilities | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 141 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 141 | |
| Total Assets | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 141 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -0 | -0 | 0 | 0 | -0 | 0 | 1 | -0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | |
| 0 | -0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | |
| Net Cash Flow | 0 | -0 | -0 | 0 | 0 | -0 | -0 | 1 | -0 | 0 | -0 | 0 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 24 | 54 | 179 | 107 | 164 | 122 | 135 | 229 | 212 | ||
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 36 | 24 | 54 | 179 | 107 | 164 | 122 | 135 | 229 | 212 | ||
| Working Capital Days | 18 | -35 | 36 | 260 | 221 | 60 | 98 | 129 | 145 | 387 | ||
| ROCE % | -2% | -3% | -3% | 7% | 25% | -31% | 3% | 2% | -3% | -13% | 3% | 17% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
12 Nov - Board approved unaudited Q2/H1 results for Sep 30, 2025: revenue Rs10,859.42 lakh; profit Rs132.14 lakh; trading window reopens Nov 15.
- Unaudited Financial Result For The Quarter And Half Year Ended September 30, 2025 12 Nov
-
Announcement under Regulation 30 (LODR)-Resignation of Director
10 Nov - Mr. Gopal Kumar Sahu (DIN:08478039) resigned as Independent Director effective Nov 10, 2025.
-
Board Meeting Intimation for Intimation Of Board Meeting
4 Nov - Board meeting Nov 12, 2025 to approve standalone unaudited H1 results and related-party transaction for period ended Sep 30, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
CTL (Formerly Rubra Medicaments Ltd) was engaged in the manufacture and sale of pharmaceutical formulations based in Hyderabad. The company is currently in the business of trading and providing different kinds of consulting services in India to all categories of clients.